Loading...
RETRACTED: Factor Analysis for Financial Performance Evaluation of Listed Chinese Medicine Companies
Author(s)
Wang, Jin
Date Issued
January 1, 2022
Type
Retracted
Abstract
Coastal city enterprises are directly related to people's health and are considered to be a sunrise industry that does not fall, while the 14th Five-Year Plan proposes to vigorously develop coastal city enterprises. In this paper, the financial data of 20 coastal city enterprises in 2019 were selected as samples, and an index system reflecting the characteristics of coastal city enterprises was constructed and analyzed by factor analysis to obtain objective enterprise performance scores and rankings. The results show that the Chinese medicine industry has large disparities at different levels but relatively small disparities in the overall ranking. The highest overall score is Yunnan Baiyao, the highest profitability and shareholder return score is Jichuan Pharmaceutical, Ealing Pharmaceutical has the strongest solvency, Baiyunshan is the best at corporate asset inventory management, Yunnan Baiyao has the greatest asset expansion, and the Zhongheng Group has the best quality of accounts receivable. It is recommended that Chinese medicine companies should take into account their own situation, strengthen their core competitive ability, and improve their corporate performance.
Citation
Mobile Information Systems, 2022, 2022